miscellaneous topics in gastroenterology waseem hamoudi m.d consultant internal medicine...
TRANSCRIPT
Miscellaneous Topics in Miscellaneous Topics in GastroenterologyGastroenterology
Waseem Hamoudi M.D
Consultant Internal Medicine
Gastroenterology & Hepatology
Peptic Ulcer DiseasePeptic Ulcer Disease
• Peptic ulcerations are excavated defects (holes) in the gastrointestinal mucosa that result when epithelial cells succumb to the caustic effects of acid and pepsin in the lumen.
• Peptic ulcer disease commonly used term to refer to ulcerations of the stomach, duodenum, or both, that is caused by acid-peptic injury.
• Histological, ulcers are necrotic mucosal defects that extend through the muscularis mucosa and into the submucosa or deeper layers.
• More superficial necrotic defects are named erosions.
History
• In the early part of the 20th century, stress and diet were considered to be the pathogenetic factors for PUD, so treatment was with bed rest and diet.
• 1950, clinicians had focused their attention on the pathogenetic role of gastric acid, so antacid therapy had become the treatment of choice.
• 1970, histamine H2 receptor antagonists became available, and acid suppression with antisecretory therapy was the treatment of choice for UD.
• 1980, proton pump inhibitors (PPI) were discovered, with more potent acid suppression and higher rates of ulcer healing.
• Using alone antisecretory drugs, will have recurrence within one year in most patients
• H. pylori was discovered in April 1982 by two Australian physicians, Dr. Barry Marshall and Dr. Robbin Warren.
• In 1983 the two doctors proposed that the bacterium is the cause of peptic (duodenal and gastric) ulcers.
• Dr. Marshall even went so far as to inoculate himself with the bacterium to prove his point.
• it soon became apparent just how widespread and serious the H. pylori threat is.
• Researches confirm that over 90 per cent of people with peptic ulcers are infected with the bacterium.
• In 1987 the Sydney gastroenterologist Thomas Borody invented the first triple therapy for the treatment of duodenal ulcers.
Causes• United Kingdome United states • Duodenal ulcer Peptic ulcer disease• Gastric ulcer( Benign) Gastroesophageal varices• Esophagitis Angiomas• Mallory-Weiss tear Mallory-Weiss tear• Gastroesophageal varices Tumors• Gastritis or gastric erosions Erosions• Tumors Dieulafoy's lesion
Jordan (Al Bashir Hospital)• Duodenal ulcer 41.90%• Esophageal varices 16.07%• Erosive gastritis/duodenitis 14.09% • Esophagitis 8.64%• Gastric ulcer 5.87%• Gastric and duodenal ulcers 3.60%• Esophageal ulcer 3.25%• Anastomotic ulcer 2.26%• Mallory-Weiss tear 1.55%• Esophageal tumor 1.41%• Gastric tumor 1.27%
Waseem H. et al. Upper G.I Bleeding in Jordan- Retrospective statistical analysis 1996-2000
Intestinal complications of ulcerative colitis
• Fibrosis
• Shortening of the colon
• Bleeding
• Stricture
• Bowel perforation
• Toxic megacolon
Systemic complications of ulcerative colitis
• Arthritis
• Iritis
• Erythema nodosum
• Pyoderma gangrenosum
• Sclerosing cholangitis
• Aphthous stomatitis
• Thromboembolic disorders
Clinical presentation of ulcerative colitis
• Bloody diarrhoea
• Fever
• Cramping abdominal pain
• Weight loss
• Frequency and urgency of defecation
• Tenesmus
• General malaise
Clinical presentation of Crohn’s disease
• Diarrhoea• Abdominal pain• Bleeding• Pyrexia• Weight loss• Fistulae• Perianal disease• General malaise
Intestinal complications of Crohn’s disease
• Fistulae
• Abscesses
• Adhesions
• Strictures
• Obstruction
Systemic complications of Crohn’s disease
• Arthritis
• Gallstones
• Malabsorption– Lactase deficiency
– Vitamin B12 deficiency
• Renal stone formation
Differences in clinical presentation between ulcerative colitis and Crohn’s disease
Ulcerative colitis Crohn’s disease
Symptoms
Pain * * * *
General malaise * * * * *
Fever * *
Diarrhoea * * * *
Stools
Blood * * * *
Mucus * * *
Pus * * *
The number of * symbols indicates the frequency with which each symptom is present
Pathological and anatomical features distinguishing ulcerative colitis from Crohn’s disease
Ulcerative colitis Crohn’s disease
Localisation Distal Segmental, proximal
Rectum affected Always 50% of cases
Intestinal wall Normal thickness Thickened
Adhesions Rare Common
Inflammation Superficial layers All layers
Ulcerations Superficial Deep
Mucous membrane Denuded Cobblestones
Granulomas 0–4% 50–70%
Lymphocytic infiltration Rare Always
Fistulae Rare Common
Aetiological theories of IBD
• Genetic
• Smoking
• Dietary
• Infection
• Immunological
• Psychological?
Pharmacological treatment of IBD
• 5-ASA-containing compounds– mesalazine
Pentasa®Asacol®Claversal®/Mesasal®/Salofalk®
– sulphasalazineSalazopyrin®
– olsalazineDipentum®
• Corticosteroids• Immunosuppressants
Treatment: indications for surgery
• Perforation
• Toxic dilatation
• Massive haemorrhage
• Chronic ill-health
• Risk of cancer
• Normally 10 liters enter the duodenum daily, of which 1 liter is absorbed by the small intestine.
• Colon resorbs most of the remaining fluid with only 100 ml fluids lose in the stool.
• Medical definition of diarrhea: a stool weight more than 250 g/day.
• Practical definition: increased stool frequency more than 3 times/day or liquidity.
• There are 2 types of diarrhea: acute diarrhea (less than 3 weeks) and chronic diarrhea (more than 3 weeks).
Acute diarrhea
• Acute diarrhea: acute onset of diarrhea and present for less than 3 weeks
• Mostly caused by infectious agents, bacterial toxins (ingested preformed in food or produced in gut) and drugs.
• Similar recent illness in family members suggests an infectious etiology.
Non-inflammatory diarrhea
• Fever absent.• Stool without blood or fecal leucocytes.• Watery stool with peri-umbilical cramps,
bloating, nausea and vomiting (small bowel enteritis) caused by either a toxin or other a toxin producing toxin or other agents that disrupt the normal absorption and secretory process in the small intestine.
How do we recognize non-inflammatory diarrhea?
By examining the absence of the leucocytes in the stool
What are the causes of Non-inflammatory diarrhea?
• Viral: Norwalk virus, Rotavirus.• Protozoa: Giardia lamblia, Cryptosporidium.• Bacterial:• Preformed entero-toxins: Staphylococcus
aureus, Bacillus cereus, and Clostridium perfringens.
• Intra-intestinal enterotoxin production: E. coli (enteropathogen) and Vibrio cholera.
• New medication.• Fecal impaction.
Inflammatory diarrhea
• Presence of fever and bloody diarrhea (dysentery) indicates colonic damage caused by invasion (shigellosis, salmonellosis, yersinia and amibiasis) or a toxin (C.difficile, E. coli 0157:H7).
• Colonic diarrhea is a small amount diarrhea in volume (< 1l/day) and associated with left lower quadrant cramps, urgency and tenesmus.
• Fecal leucocytes are present in infections with invasive organisms.
What are the causes of inflammatory diarrhea?
• Viral: Cytomegalovirus.• Bacterial:1. Cytotoxin production: E. coli 0157:H7
(enterohemorhagic), Vibrio parahemolyticcus and Clostridium difficile.
2. Mucosal invasion: Shigella, Salmonella, enteroinvasive E. coli, aeromonas and Yersinia.
3.Bacterial proctitis: Chlamydia, N. gonorrhea.• Protozoa: E. histolytica.• Other: Ischemic colitis, I.B.D. and radiation
colitis.